![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 498/04 | (2006.01) |
A61K 31/553 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3317284 |
(13) | Kind of document | T |
(96) | European patent application number | 16733600.7 |
Date of filing the European patent application | 2016-07-01 | |
(97) | Date of publication of the European application | 2018-05-09 |
(45) | Date of publication and mention of the grant of the patent | 2019-10-30 |
(46) | Date of publication of the claims translation | 2020-01-27 |
(86) | Number | PCT/EP2016/065455 |
Date | 2016-07-01 |
(87) | Number | WO 2017/001645 |
Date | 2017-01-05 |
(30) | Number | Date | Country code |
201562188029 P | 2015-07-02 | US |
(72) |
BRAUN, Marie-Gabrielle, US
ELLIOTT, Richard, GB
HANAN, Emily, US
HEALD, Robert Andrew, GB
MACLEOD, Calum, GB
STABEN, Steven T., US
|
(73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Benzoksazepino oksazolidinono junginiai ir jų naudojimo būdai |
BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE |
Payment date | Validity (years) | Amount | |
2025-06-19 | 10 | 231.00 EUR |
2026-07-01 |